Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone.
Heesen
C
C
Bruegmann
M
M
Gbdamosi
J
J
Koch
E
E
Mönch
A
A
Buhmann
C
C
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008942:Mitoxantrone / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*
D000970:Antineoplastic Agents; D008942:Mitoxantrone